Molecular characterization of upper tract urothelial carcinoma in the era of next-generation sequencing: a systematic review of the current literature

MR Hassler, F Bray, JWF Catto, AP Grollman… - European urology, 2020 - Elsevier
Context While upper tract urothelial carcinoma (UTUC) share histological appearance with
bladder cancer (BC), the former has differences in etiology and clinical phenotype consistent …

The dynamic roles of the bladder tumour microenvironment

YC Lee, HM Lam, C Rosser, D Theodorescu… - Nature Reviews …, 2022 - nature.com
Bladder cancer is a prevalent but currently understudied cancer type and patient outcomes
are poor when it progresses to the muscle-invasive stage. Current research in bladder …

[HTML][HTML] Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

G Vandekerkhove, JM Lavoie, M Annala… - Nature …, 2021 - nature.com
Molecular stratification can improve the management of advanced cancers, but requires
relevant tumor samples. Metastatic urothelial carcinoma (mUC) is poised to benefit given a …

[HTML][HTML] Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression

S Jana, S Brahma, S Arora, CL Wladyka, P Hoang… - Cancer Cell, 2023 - cell.com
We uncover a tumor-suppressive process in urothelium called transcriptional-translational
conflict caused by deregulation of the central chromatin remodeling component ARID1A …

[HTML][HTML] A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer

S Li, A Wong, H Sun, V Bhatia, G Javier, S Jana… - Nature Genetics, 2024 - nature.com
Available genetically defined cancer models are limited in genotypic and phenotypic
complexity and underrepresent the heterogeneity of human cancer. Here, we describe a …

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free …

SK Pal, D Bajorin, N Dizman, J Hoffman‐Censits… - Cancer, 2020 - Wiley Online Library
Background Infigratinib (BGJ398) is a potent and selective fibroblast grown factor receptor 1
to 3 (FGFR1‐3) inhibitor with significant activity in patients with advanced or metastatic …

[HTML][HTML] Spatial immunephenotypes of distant metastases but not matched primary urothelial carcinomas predict response to immune checkpoint inhibition

F Erlmeier, N Klümper, L Landgraf, PL Strissel, R Strick… - European Urology, 2023 - Elsevier
Background The value of programmed cell death ligand-1 (PD-L1) to predict durable
responses to immune checkpoint inhibitors (ICIs) in metastatic urothelial carcinoma (mUC) is …

Metastatic bladder cancer expression and subcellular localization of Nectin-4 and Trop-2 in variant histology: A rapid autopsy study

F Ghali, F Vakar-Lopez, MP Roudier, J Garcia… - Clinical genitourinary …, 2023 - Elsevier
Abstract Background Nectin-4 and Trop-2 are transmembrane targets of FDA-approved
antibody-drug conjugates (ADC) Enfortumab-vedotin (EV) and Sacituzumab govitecan (SG) …

[HTML][HTML] Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

TN Clinton, Z Chen, H Wise, AT Lenis, S Chavan… - Cell reports, 2022 - cell.com
Precision oncology relies on the accurate molecular characterization of individual patients
with cancer at the time of treatment initiation. However, tumor molecular profiles are not …

[HTML][HTML] Insights into the metastatic cascade through research autopsies

S Hessey, P Fessas, S Zaccaria, M Jamal-Hanjani… - Trends in Cancer, 2023 - cell.com
Metastasis is a complex process and the leading cause of cancer-related death globally.
Recent studies have demonstrated that genomic sequencing data from paired primary and …